Public Statement 10/7/21
This week, the Columbus Dispatch published an article reflecting experiences of former and current staff of Equitas Health. Those of us who work here know that our growth and evolution has been challenging. We cannot – and will not – ignore the historical and current impact that our Black, Indigenous, and People of Color (BIPOC) stakeholders are feeling.
To that end, Equitas Health acknowledges the impact white supremacy culture and structural racism has on the BIPOC community, members of historically minoritized communities in America and in the workplace. Equitas Health acknowledges the exclusion of BIPOC people from the greater LGBTQ+ community. Equitas Health apologizes for any role we had in perpetuating such.
The BIPOC community deserves more, and we are unequivocally committed to doing more. We appreciate the strength and courage it took for the community and our employees to call us in, while challenging the organization to do better.
Effective as of this communication, we will be posting a position for a Chief People & Culture Officer. This executive-level role will oversee culture, human resources, and diversity, equity, and inclusion. This role is one of the many next steps in our journey to become a more anti-racist organization.
To further demonstrate our commitment to diversity, equity, inclusion and belonging, Equitas Health is undertaking the following actions with a strategy including implementation timelines, responsible employees/parties, and target dates:
We are hopeful about the future of the organization as we continue to grow and expand our services. To learn more about our Diversity & Inclusion activities, please visit: Diversity and Inclusion – Equitas Health.
Public Statement 9/21/24
Our focus remains on integrating our programs to better serve historically neglected communities, always with an understanding of the unique and intersectional needs of the diverse LGBTQ+ population.
Public Statement 8/26/24
Johnson & Johnson, one of the world’s largest drugmakers, announced last Friday that it will discontinue upfront 340B pricing on two medications for disproportionate share hospital (DSH) covered entities. The move is part of a sustained campaign by large drug manufacturers to undermine the federal 340B Drug Pricing Program for participating hospitals and covered entities such as Equitas Health.
Public Statement 8/14/24
Blog 3/29/24
Equitas Health is pleased to announce that a collective bargaining agreement has been reached with Equitas Health Workers United Local #6609. Members of the bargaining unit voted this week, and the result was resounding support for ratification of the agreement.
Blog 2/26/24
Blog 6/2/23
Public Statement 9/21/24
Our focus remains on integrating our programs to better serve historically neglected communities, always with an understanding of the unique and intersectional needs of the diverse LGBTQ+ population.
Public Statement 8/26/24
Johnson & Johnson, one of the world’s largest drugmakers, announced last Friday that it will discontinue upfront 340B pricing on two medications for disproportionate share hospital (DSH) covered entities. The move is part of a sustained campaign by large drug manufacturers to undermine the federal 340B Drug Pricing Program for participating hospitals and covered entities such as Equitas Health.
Public Statement 8/14/24